Detalles de la búsqueda
1.
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.
Br J Cancer
; 130(8): 1249-1260, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361045
2.
Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment.
EMBO J
; 39(6): e104013, 2020 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32009247
3.
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ann Surg Oncol
; 30(1): 35-45, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36085390
4.
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer.
Gynecol Oncol
; 166(2): 334-343, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35738917
5.
Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism.
Br J Cancer
; 119(7): 847-854, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30293997
6.
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
Br J Cancer
; 119(3): 330-338, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29955134
7.
ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Multicenter, Retrospective Study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ann Surg Oncol
; 30(1): 46-47, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335272
8.
Morphology and tumour-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survival.
Histopathology
; 73(6): 1002-1012, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30007074
9.
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.
Gynecol Oncol
; 150(1): 151-157, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753392
10.
Genetic Versus Epigenetic BRCA1 Silencing Pathways: Clinical Effects in Primary Ovarian Cancer Patients: A Study of the Tumor Bank Ovarian Cancer Consortium.
Int J Gynecol Cancer
; 27(8): 1658-1665, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28691938
11.
Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages.
Proc Natl Acad Sci U S A
; 111(34): E3562-70, 2014 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25114209
12.
Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts.
J Pathol
; 232(1): 43-56, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24014111
13.
Vaccinia virus induces programmed necrosis in ovarian cancer cells.
Mol Ther
; 21(11): 2074-86, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23985697
14.
B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis.
Proc Natl Acad Sci U S A
; 108(26): 10662-7, 2011 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-21670304
15.
Pre-Operative Malnutrition in Patients with Ovarian Cancer: What Are the Clinical Implications? Results of a Prospective Study.
Cancers (Basel)
; 16(3)2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339372
16.
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer.
Leukemia
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637689
17.
The peritoneal tumour microenvironment of high-grade serous ovarian cancer.
J Pathol
; 227(2): 136-45, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22322968
18.
In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients.
Cancers (Basel)
; 15(12)2023 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37370765
19.
Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma.
J Cancer Res Clin Oncol
; 149(6): 2523-2536, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35763108
20.
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.
J Ovarian Res
; 16(1): 150, 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37525239